drugset / Trial / NCT01893879

Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema

NCT01893879 ↗

Terminated 14 enrolled Stanford University
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized clinical trial studies an investigational drug in preventing lymphedema in patients at high risk after undergoing axillary lymph node dissection. The study drug may prevent lymphedema in patients undergoing axillary lymph node dissection.

Timeline

Start
2014-04
Primary completion
2015-04
Completion
2015-04

Outcome

Outcome not reported

Stopped (Enrollment): “insufficient enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject (RS)2-(3-benzoylphenyl)-propionic acid Unknown — Oral

Indications